期刊文献+

原发性肾病综合征的预防性抗凝治疗 被引量:3

原文传递
导出
摘要 血栓形成(thrombosis)是肾病综合征(nephrotic syndrome,NS)的常见并发症之一,特别是原发性膜性肾病,不仅导致患者易进展至终末期肾脏病(end-stage renal disease,ESRD),而且增加了NS患者ESRD基础上的心血管事件的发生率[1]。
出处 《中华临床医师杂志(电子版)》 CAS 2012年第17期5202-5204,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献6

  • 1Shi J,Gilbert GE.Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid binding sites. Blood . 2003
  • 2Bennett A,Cameron JS.Platelet hyperagregability in the nephrotic syn-drome which is not dependent on arachidonic acid mabolism or onPlasma albumin concentration. Clinical Nephrology . 1987
  • 3Velasquez FF,Garcia PN,Ruiz MN.Idiopathic nephrotic syndrome ofthe adult with asymptomatic thrombosis of the renal vein. Am J Neph-rol . 1988
  • 4Bellomo R,Atkins RC.Membranous nephropathy and thrombo-embol-ism:Is prophylactic anticoagulation warranted. Nephron . 1993
  • 5周云杉,应志涛,李茹,朱军,栗占国.淋巴瘤患者血清中抗磷脂自身抗体的临床及免疫学意义[J].中华医学杂志,2011,91(37):2607-2610. 被引量:6
  • 6徐士欣,焦连亭,包承鑫.血小板活化与血液凝固[J].国际检验医学杂志,2004,26(5):480-482. 被引量:5

二级参考文献13

  • 1宁新荣,赵义,刘宗平,栗占国.抗β_2-糖蛋白Ⅰ抗体在系统性红斑狼疮中的临床意义[J].中华风湿病学杂志,2006,10(4):213-216. 被引量:7
  • 2Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Thromb Haemost, 2006, 7 : 295-306.
  • 3Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725.
  • 4Pusterla S, Previtali S, Marziali S, et al. Antiphospholipid antibodies in lyrnphoma: prevalence and clinical significanee. Hematol J, 2004, 5: 341-346.
  • 5Bairey O, Blickstein D, Monselise Y, et al. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non- Hodgkin's lymphoma. Eur J Haematol, 2006, 76: 384-391.
  • 6Stasi R, Stipa E. Antiphospholipid antibodies: prevalence, clinical significance and colrelation to eytokine levels in acute myeloid leukemia and non-Hodgkin' s lymphoma. Thromb Haemnst, 1993, 70: 568-572.
  • 7Genvresse I, Luftner D, Spath-Schwalbe E, et al. Prevalence and clinical significance of anticardiolipin and anti-[32-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma. Eur J Haematol, 2002, 68: 84-90.
  • 8A Cheson BD, Pfistne B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol, 2007, 25 : 579- 586.
  • 9Kaburaki J, Kuwana M, Yamamoto M, et al. Clinical significance of phospholipids- dependent anti-beta 2- glycoprotein I ( beta 2- GPI) antibodies in systemic lupus erythematosus. Lupus, 1995, 4 : 472-476.
  • 10Tsutsumi A, Matsuura E, Ichikawa K, et al. Antibodies to β2- glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum, 1996, 39: 1466- 1474.

共引文献9

同被引文献63

引证文献3

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部